D-NOME
PrivateLast Round
Seed
Jan 21, 2023
Est. Valuation
$500,000
Total Funding Raised
$1.61M
Momentum Score
50 /100
Company Overview
D-NOME is a biotechnology company that develops reagents and kits for molecular diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
D-NOME Comps
Public and private peers based on sector, stage, and business model.
D-NOME Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 21, 2023 | ||||
| Grant | Dec 1, 2021 | ||||
| Pre Seed | Sep 28, 2021 |
Key People
Founding team and executive leadership
D-NOME Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| Seeders | Seed |
| 3i Partners | Seed |
| Nidhi Prayas | Grant |
| Ankur Capital | Seed |
| Campus Fund | Seed |
| Hello Tomorrow | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors grew 179% MoM, reaching 2.1K.
- May 2, 2025
Grew 75% QoQ from 4 to 7 employees.
D-NOME Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about D-NOME's valuation, stock price, and market status.
